Skip to content

Prevalence Estimate Chlamydia And gonorrhoea Netherlands, second edition

Prevalence Estimate Chlamydia And gonorrhoea Netherlands, second edition - PECAN-II

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON51506
Enrollment
1850
Registered
2022-06-03
Start date
2022-10-10
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gonorroe Sexually Transmitted Infections (STI)

Interventions

None listed

Sponsors

RIVM
Lead Sponsor

Eligibility

Age
16 Years to 64 Years

Inclusion criteria

Inclusion criteria: Age 16.5-34 years and sexually active

Exclusion criteria

Exclusion criteria: age below 16.5 years or above 34 years; no sexual experience (no experience with vaginal or anal intercourse)

Design outcomes

Primary

MeasureTime frame
Proportion chlamydia and gonorrhoea positive among participants and estimates thereof for the entire population and by risk factor / subgroup (or combinations thereof).

Secondary

MeasureTime frame
- To evaluate the validity of current surveillance data, by getting better insight into the prevalence and risk factors among the population groups visiting the general practice or STI clinic for STI testing and those who do not seek STI Healthcare (but have been at risk for STI). - Gain better insight into the factors (demographic and behavioral) associated with STIs in the Netherlands. - To obtain data that can serve as input for transmission models in the Netherlands to predict the impact of interventions. - To obtain insights in changes over time of the STI prevalence by comparing the results from this study with the results of the previous edition of PECAN (2017).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026